Home / Import refusals / AEK-8213590-4/11/1

FDA Import Refusal AEK-8213590-4/11/1 — AbbVie Inc.

AbbVie Inc. — FEI 3009751352

The FDA refused shipment AEK-8213590-4/11/1 from AbbVie Inc. (United States) on March 4, 2025. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
March 4, 2025
Country
United States
Product Category
Drugs and Biologics
Product Code
66VIY99 MISCELLANEOUS PATENT MEDICINES, ETC.
Charges
75

Recent inspections

  • 1299008 (NAI Mon Apr 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1277010 (NAI Thu Aug 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1257605 (NAI Thu Jun 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1231413 (NAI Fri Apr 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1198013 (VAI Tue Jan 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • AEK-0768117-3/10002/1A (Fri Jul 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-9968726-6/20003/1 (Wed Jan 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Devices)
  • 799-9161571-9/10001/1 (Sun Dec 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-8712399-1/10001/1 (Fri Dec 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-7803787-9/10001/1 (Tue Nov 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources